Invivotek offers custom & standard pre-clinical services for NASH studies. We help clients study mechanism of action, evaluate potential target genes and explore drug efficacy biomarkers.
Genesis Drug Discovery & Development (GD3) is a fully integrated CRO.
- Discovery Biology, Hit to Lead and Lead Optimization
- Synthetic Organic & Medicinal Chemistry (including IND and IP support)
- In vitro ADME
- Assay and Biomarker development
- Recombinant Protein Expression/Purification
- DMPK/in-vivo pharmacology & GLP Toxicology
Our clients span a wide range of therapeutic areas including oncology, ophthalmology, inflammation/autoimmunity, metabolic diseases, gene therapy, RNA targets and microbiome.